"Procainamide" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A class Ia antiarrhythmic drug that is structurally-related to PROCAINE.
| Descriptor ID |
D011342
|
| MeSH Number(s) |
D02.065.277.650 D02.241.223.100.050.500.875 D02.241.223.100.100.650 D02.455.426.559.389.127.020.937.875 D02.455.426.559.389.127.085.650
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Procainamide".
Below are MeSH descriptors whose meaning is more specific than "Procainamide".
This graph shows the total number of publications written about "Procainamide" by people in this website by year, and whether "Procainamide" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1998 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Procainamide" by people in Profiles.
-
Conversion efficacy and safety of intravenous ibutilide compared with intravenous procainamide in patients with atrial flutter or fibrillation. J Am Coll Cardiol. 1998 May; 31(6):1414-9.
-
The antiarrhythmic effects of d-sotalol. Am Heart J. 1987 Sep; 114(3):539-44.
-
Chronic flecainide therapy selected by electrophysiology testing of intravenous flecainide. Am Heart J. 1987 Jul; 114(1 Pt 1):18-25.
-
Comparative efficacy of pirmenol and procainamide in a drug-resistant population with ventricular tachycardia. J Clin Pharmacol. 1987 Jul; 27(7):481-6.
-
Lorcainide therapy in a cardiac arrest population. Am Heart J. 1986 Apr; 111(4):648-53.
-
Antiarrhythmic drug efficacy at electrophysiology testing: predictive effectiveness of procainamide and flecainide. Am Heart J. 1986 Apr; 111(4):632-8.
-
Electrophysiologic evaluation of the antiarrhythmic effects of N-acetylprocainamide for ventricular tachycardia secondary to coronary artery disease. Am J Cardiol. 1985 Nov 15; 56(13):877-81.
-
Flecainide: long-term treatment using a reduced dosing schedule. Am J Cardiol. 1985 Jan 01; 55(1):79-83.
-
Long-term lorcainide therapy in patients with ventricular tachycardia. Am Heart J. 1985 Jan; 109(1):33-40.
-
Long term lorcainide therapy guided by electrophysiology studies. Acta Cardiol. 1985; 40(6):621-36.